SWMCX
Price
$14.48
Change
+$0.04 (+0.28%)
Updated
Oct 17 closing price
Net Assets
2.19B
VIMAX
Price
$358.27
Change
+$0.63 (+0.18%)
Updated
Oct 17 closing price
Net Assets
201.28B
Interact to see
Advertisement

SWMCX vs VIMAX

Header iconSWMCX vs VIMAX Comparison
Open Charts SWMCX vs VIMAXBanner chart's image
Schwab ® US Mid-Cap Index
Price$14.48
Change+$0.04 (+0.28%)
VolumeN/A
Net Assets2.19B
Vanguard Mid Cap Index Admiral
Price$358.27
Change+$0.63 (+0.18%)
VolumeN/A
Net Assets201.28B
SWMCX vs VIMAX Comparison Chart in %
View a ticker or compare two or three
VS
SWMCX vs. VIMAX commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SWMCX is a Hold and VIMAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIMAX has more cash in the bank: 201B vs. SWMCX (2.19B). VIMAX pays higher dividends than SWMCX: VIMAX (1.48) vs SWMCX (1.27). SWMCX was incepted earlier than VIMAX: SWMCX (8 years) vs VIMAX (24 years). VIMAX (0.05) is less costly to investors than SWMCX (0.04). VIMAX is a more actively managed with annual turnover of: 16.00 vs. SWMCX (13.00). SWMCX has a lower initial minimum investment than VIMAX: SWMCX (0) vs VIMAX (3000). SWMCX annual gain was more profitable for investors over the last year : 684.34 vs. VIMAX (7.58). SWMCX return over 5 years is better than : 2600.39 vs. VIMAX (57.32).
SWMCXVIMAXSWMCX / VIMAX
Total Expense Ratio0.040.0580%
Annual Report Gross Expense Ratio0.040.0580%
Fund Existence8 years24 years-
Gain YTD444.8529.7074,583%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.19B201B1%
Annual Yield % from dividends1.271.4886%
Returns for 1 year684.347.589,025%
Returns for 3 years1775.7049.703,573%
Returns for 5 years2600.3957.324,537%
Returns for 10 yearsN/A140.93-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NVX1.980.02
+1.02%
NOVONIX Limited
CXM7.620.05
+0.66%
Sprinklr
ABVC2.92N/A
N/A
ABVC BioPharma
ATIIU10.59N/A
N/A
Archimedes Tech SPAC Partners II Co
MDGL438.90-3.23
-0.73%
Madrigal Pharmaceuticals